![Petra Budde](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Petra Budde
Chief Tech/Sci/R&D Officer at
ONCE HLDG
Profile
Petra Budde currently works at Oncimmune Holdings Plc, as Chief Scientific Officer from 2023.
Petra Budde active positions
| Companies | Position | Start |
|---|---|---|
| ONCE HLDG | Chief Tech/Sci/R&D Officer | 01/01/2023 |
Oncimmune Germany GmbH
 Oncimmune Germany GmbH BiotechnologyHealth Technology Develops antibody and autoantibody biomarker discovery platform | Chief Tech/Sci/R&D Officer | 01/01/2023 |
Former positions of Petra Budde
| Companies | Position | End |
|---|---|---|
Protagen AG
 Protagen AG BiotechnologyHealth Technology Specializes in the development of novel diagnostic and companion diagnostic tests | Chief Tech/Sci/R&D Officer | 01/01/2019 |
Training of Petra Budde
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
18
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Bielefeld
 University of Bielefeld Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagen AG
Protagen AG BiotechnologyHealth Technology Specializes in the development of novel diagnostic and companion diagnostic tests | Health Technology |
Oncimmune Holdings Plc
 Oncimmune Holdings Plc BiotechnologyHealth Technology Provides cancer detection and diagnosis services | Health Technology |
Oncimmune Germany GmbH
Oncimmune Germany GmbH BiotechnologyHealth Technology Develops antibody and autoantibody biomarker discovery platform | Health Technology |
- Stock Market
- Insiders
- Petra Budde
